Organic Chemistry Methods TRIZ Cases

Amorphous obicetrapib hemicalcium improves stability, solubility, and dissolution while enabling higher-yield scalable manufacture.

A transition-metal organometallic dopant improves OLED charge transport and exciton generation to boost brightness and lower driving voltage.

A thiophene o-nitrobenzyl protecting group releases hydroxamic acids under light while fluorescence change tracks reaction completion and helps avoid harsh deprotection.

Heteroaryl compounds selectively inhibit KRAS G12C with strong cellular potency, low oral doses, and favorable pharmacokinetics for cancer therapy.

A hybrid OLED emissive layer uses phosphorescence, small-FWHM emitters, and optional TADF to improve color purity, efficiency, and lifetime.

Pyrene- and anthracene-based emission layers balance low driving voltage, high luminous efficiency, and longer OLED lifespan.

A phosphorescent and TADF-mediated OLED layer transfers energy to a small-FWHM emitter, improving color purity, efficiency, and lifetime.

Dual energy-transfer components drive small-FWHM emitters to balance OLED efficiency, lifetime, and BT-2020/DCI-P3 color purity.

Deuteration and radiolabeling slow cholesterol metabolism while enabling PET/CT tracking for infection therapy and drug monitoring.

Triazine derivatives target coronavirus 3CL protease to inhibit viral replication and support safer COVID-19 therapeutic development.

Varying host T1 values across tandem OLED emitting units improves efficiency and extends lifespan through better exciton and charge control.

Controlled solvent, pH, and cooling conditions produce stable R-MDMA HCl Form I with high optical purity, solubility, and humidity stability.

A new Fezolinetant intermediate route uses chiral alanine and mild conditions to prevent racemization, raise chiral purity, and lower cost.

Deuterated host materials in a green emitting layer improve OLED stability, operational efficiency, and lifespan without changing the core device structure.

A chiral tetradentate Pt/Pd complex suppresses racemization and ligand distortion to deliver stable circularly polarized OLED emission.

A TADF blue OLED layer with a narrow-spectrum emitter and triplet management improves color purity, efficiency, and operating lifetime.

Hole scavengers and excitation energy transfer components help OLED emitters achieve narrow spectra, long lifetime, and high efficiency.

Acid-catalyzed reaction of Compound B with crotonaldehyde delivers a sotorasib intermediate at high yield and purity without hazardous solvents.

Novel pyrazole aniline compounds inhibit YAP/TAZ-TEAD with stronger efficacy, lower toxicity, and improved pharmacokinetic properties.

Direct sulfuric acid deprotection forms selumetinib sulfate without neutralization, enabling stable crystal forms with fewer impurities.

A Pd or Pt emissive compound enables saturated OLED color emission from a simpler organic layer, improving color purity and efficiency.

Selective cooling and phase separation recover naphthalene from rerun column bottom residue with over 97% purity and 77.7% efficiency.

Zn coordination nanoparticles change photoresist solubility under illumination to improve EUV pattern resolution, sensitivity, and line roughness.

An amine compound with naphthylene groups improves hole transport, electron blocking, and thermal stability in organic EL devices.

A low-temperature DMF-acetone crystallization route yields Compound 1 Form II with higher thermal stability and purity during pharmaceutical processing.

Polycyclic aromatic dopants and an anthracene host improve OLED luminous efficacy while preserving organic-layer stability and device lifespan.

Acid salt crystal forms improve solubility, stability, and bioavailability of quaternary fused ring BCR-ABL1 inhibitors against resistant CML mutants.

A stable crystal form of a pyrrole capsid assembly inhibitor blocks HBV replication while addressing persistent cccDNA in hepatocytes.

Novel OLED compounds harvest singlet and triplet energy through delayed fluorescence, improving blue emitter lifetime beyond conventional limits.

Amide-solvent solvate crystallization replaces fine needle precipitates with stable crystals that filter faster and retain less moisture.

Aromatic polyester composition enables high-index optical lenses with low b value while maintaining moist heat and hydrolysis resistance.

A Formula 1 organometallic compound with TADF doping boosts carrier recombination to raise luminance, cut driving voltage, and speed OLED response.

A bifunctional cyclohexyl PROTAC improves prostate cancer treatment by binding androgen receptors and driving their selective degradation.

Deuterated host and hole-transport compounds curb electron excess in OLED layers, improving emission efficiency, stability, and lifetime.

Pt and Pd organometallic emitters produce saturated RGB light in OLEDs while avoiding absorption filters and complex white-emission stacks.

A tailored divalent platinum complex improves green OLED efficiency, chromaticity, and stability for longer-lived display and lighting emission.

Amino acid-linked CBD prodrugs improve solubility, permeability, and PEPT1 uptake for more precise site-specific cannabinoid delivery.

Liquefied gas followed by inert gas clears residual organics from a propylene oxide catalyst bed, shortening reactor opening downtime.

Crystalline Setogepram polymorphs and sodium salts improve handling, stability, and dissolution through controlled solvent removal and cooling.

Characterized LSD salt polymorphs improve stability, dissolution, and bioavailability through systematic crystal-form screening.

A tailored organometallic emitter raises the host-dopant energy gap and suppresses aggregation to improve OLED emission and reliability.

An emission layer using fused polycyclic compounds improves hole-electron recombination to boost OLED efficiency, lower driving voltage, and extend lifespan.

A ketoprofen lysine co-crystal improves crystallinity, reduces particle size, and speeds dissolution for pain and inflammatory treatment.

Controlled crystallization of emetine dihydrochloride improves yield and purity while enabling antiviral use against coronavirus and Zika infections.

Specific triazolopyrimidinone substituents improve solubility while preserving potent, selective A2aR and A2bR antagonism for cancer use.

A heterocyclic layer material tunes band gap and T1 to improve hole transport, suppress electron invasion, lower voltage, and extend OLED life.

A host material with higher triplet energy blocks Dexter transfer around an organometallic emitter, improving luminance, voltage, and response speed.

Palladium-catalyzed thiotritylation enables milder, faster synthesis of aryl tritylsulfanyl and SF5-containing compounds.

Selective solvent and anti-solvent crystallization isolates tafamidis Form 4 with high purity while avoiding Form 1 contamination.

An intermediary organic compound improves charge balance, color purity, low-voltage emission, and OLED lifespan by stabilizing transport layers.